Cell And Gene Therapy Manufacturing Services Market Scope And Analysis

  • Report Code : TIPRE00024304
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 216
Buy Now

Cell and Gene Therapy Manufacturing Services Market Scope and Analysis by 2030

Buy Now


Cell and Gene Therapy Manufacturing Services Market Report Scope

Report Attribute Details
Market size in 2022 US$ 7,581.97 Million
Market Size by 2030 US$ 26,724.90 Million
Global CAGR (2022 - 2030) 17.1%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Type
  • Cell Therapy
  • Gene Therapy
By Indication
  • Cancer
  • Orthopaedics
By Application
  • Clinical Manufacturing
  • Commercial Manufacturing
By End User
  • Pharmaceutical
  • Biotechnology Companies
  • Contract Research Organization
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Charles River Laboratories International Inc
  • Lonza Group AG
  • WuXi AppTec Co Ltd
  • Catalent Inc
  • Takara Bio Inc
  • Nikon Corp
  • FUJIFILM Holdings Corp
  • National Resilience Inc
  • Cell and Gene Therapy Manufacturing Services Market News and Recent Developments

    The cell and gene therapy manufacturing services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the cell and gene therapy manufacturing services market are listed below:

    • RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell and Gene Therapy industry, announce their integration, creating a unified business that will operate under the RoslinCT brand. The integration, facilitated by GHO Capital, a global investment firm, aims to establish a dominant player in the Advanced Cell and Gene Therapy CDMO market. (Source: RoslinCT, Press Release, June 2023)
    •  Cincinnati Children's Hospital Medical Center and the research service provider CTI Clinical Trial & Consulting Services have agreed to form a company that will focus on providing cell and gene therapy manufacturing services to the biotechnology and pharmaceutical industries. (Source: Cincinnati Children's Hospital Medical Center, Press Release, December 2021)

    Cell and Gene Therapy Manufacturing Services Market Report Coverage and Deliverables

    The “Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

    • Cell and gene therapy manufacturing services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Cell and gene therapy manufacturing services market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Cell and gene therapy manufacturing services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cell and gene therapy manufacturing services market
    • Detailed company profiles